D.N.A. Biomedical Solutions Aktie
ISIN: IL0011038523
25.02.2025 23:08:25
|
Ginkgo Bioworks Holdings, Inc. Q4 Loss Narrows
(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) released Loss for fourth quarter of -$107.53 million
The company's earnings totaled -$107.53 million, or -$2.00 per share. This compares with -$211.69 million, or -$4.28 per share, last year.
The company's revenue for the period rose 26.2% to $43.85 million from $34.76 million last year.
Ginkgo Bioworks Holdings, Inc. earnings at a glance (GAAP) :
-Earnings: -$107.53 Mln. vs. -$211.69 Mln. last year. -EPS: -$2.00 vs. -$4.28 last year. -Revenue: $43.85 Mln vs. $34.76 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu D.N.A. Biomedical Solutions Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |